PharmaStem Wins Judgment in Umbilical-Cord Patent Case

Law360, New York (November 3, 2003, 12:00 AM EST) -- A jury in the U.S. District Court for the District of Delaware has found that several of the nation's largest umbilical-cord blood banks willfully violated patents covering the medically valuable tissues, the Wall Street Journal reported on Monday.

The jury stipulated a "reasonable royalty rate" of 6.125% and awarded the plaintiff $7.1 million, according to court records.

On Feb. 22, 2002, PharmaStem Therapeutics Inc., of Wayne, Pa., sued ViaCell Inc., Boston; Cryo-Cell International Inc., Clearwater, Fla.; CorCell Inc., Philadelphia; and CBR Systems Inc., San Bruno, Calif,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.